Sara Zarei, MD, PHD
NPI 1417416637 · Neurology Physician · Orange, CA
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1417416637
- Entity type
- Individual
- Primary specialty
- Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Female
- Sole proprietor
- Yes
- License
- 320665 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
7 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
41 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| New Patient Office Or Other Outpatient Visit With a High Level of Medical Decision Making, If Using Time, 60 Minutes Or More99205 | 26 | $236 |
| Evaluation of Neuropsychological Test, First Hour96132 | 15 | $136 |
Typical Medicare-allowed amounts for these services range $136–$236 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Celecoxib | 148 | 31 |
| Gabapentin | 106 | 38 |
| Donepezil Hcl | 64 | 23 |
| Baclofen | 57 | 19 |
| Ofatumumabbrand: Kesimpta Pen | 36 | — |
| Memantine Hcl | 33 | 11 |
| Duloxetine Hcl | 32 | — |
| Carbidopa/Levodopabrand: Carbidopa-Levodopa |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,640 across 125 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 224 W 35th St, Ste 500 Pmb 426New York, NY 10001Phone: (760) 845-0956
Registry dates
- Enumerated
- 2019-03-18
- Last updated
- 2024-11-27
- Certified
- 2024-11-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.